# E2P4 Labs – FDA Inspection, Sep 17, 2024

Source: https://www.keypedia.com/records/fda_inspections/e2p4-labs/91e794df-cc3c-41c1-aae0-87b694efe73b
Source feed: FDA_Inspections

> FDA inspection 1250451 of E2P4 Labs, September 17, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 1271. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250451
- Company Name: E2P4 Labs
- Inspection Date: 2024-09-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 3

## Related Officers

- [Company Rep](https://www.keypedia.com/people/maira-p-brading/892072f4-e584-48d1-890c-e0a47dfbdffa)
- [Issuing Officer](https://www.keypedia.com/people/ramon-l-gonzalez-prieto/f03487d2-7c8c-407f-8270-a838f7a7d127)

Company: https://www.keypedia.com/companies/e2p4-labs/29ea74de-4cc8-41d4-aab4-7f5a7852334d

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
